Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Journal of Molecular Biology|April 28, 2009
Structural basis for bivalent Smac-mimetics recognition in the IAP protein familyFederica Cossu, Mario Milani, Eloise Mastrangelo, et al.Organic & Biomolecular Chemistry|January 24, 2015
Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactionsFabio Doro, Cinzia Colombo, Chiara Alberti, et al.Bioorganic & Medicinal Chemistry|October 6, 2012
Homo- and heterodimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part I: SynthesisLeonardo Manzoni, Laura Belvisi, Aldo Bianchi, et al.Chemmedchem|April 11, 2012
Synthesis of Gd and (68)Ga complexes in conjugation with a conformationally optimized RGD sequence as potential MRI and PET tumor-imaging probesLeonardo Manzoni, Laura Belvisi, Daniela Arosio, et al.Nature Communications|August 2, 2020
Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral SclerosisLuca Muzio, Riccardo Sirtori, Davide Gornati, et al.Molecular Cancer Therapeutics|November 9, 2005
Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonistLaura Belvisi, Teresa Riccioni, Marcella Marcellini, et al.Bioconjugate Chemistry|July 10, 2012
Design, synthesis, and biological evaluation of novel cRGD-paclitaxel conjugates for integrin-assisted drug deliveryMichael Pilkington-Miksa, Daniela Arosio, Lucia Battistini, et al.Journal of Medicinal Chemistry|January 10, 2018
Interfering with HuR-RNA Interaction: Design, Synthesis and Biological Characterization of Tanshinone Mimics as Novel, Effective HuR InhibitorsLeonardo Manzoni, Chiara Zucal, Danilo Di Maio, et al.Bioorganic & Medicinal Chemistry|October 16, 2012
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterizationDaniele Lecis, Eloise Mastrangelo, Laura Belvisi, et al.Bioorganic & Medicinal Chemistry|July 22, 2009
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapyPierfausto Seneci, Aldo Bianchi, Cristina Battaglia, et al.Pageof 4